News
Efficacy results of Ipsen’s Phase 2 ELMWOOD trial (LB25222/OS089 ... since June 2024 for the treatment of Primary Biliary Cholangitis (PBC), was developed by GENFIT, from initial discovery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback